BEIJING, June 30, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, Dehaier Medical reminds shareholders that it will hold its 2014 Annual General Meeting at 9:00 p.m., Eastern Time, on Monday, July 28, 2014 in Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing 100856 China.
At our Annual Meeting, our shareholders will vote on the following proposals:
(i) To elect two Class I members of the Board of Directors, to serve a term expiring at the Annual Meeting of Shareholders in 2017 or until their successors are duly elected and qualified;
(ii) To ratify the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014;
(iii) To approve the Company's 2014 Share Incentive Plan; and
(iv) To transact any other business properly coming before the meeting.
Dehaier warmly welcomes all shareholders to participate in the meeting and encourages you to vote either at or before the meeting by providing a proxy to approve the above matters. Shareholders may vote by telephone or on the Internet or may participate in the meeting in person. Shareholders who attend the meeting conference call should provide their proxies prior to the meeting.
- To vote by telephone, please call 1-800-652-8683.
- To vote on the Internet, please visit www.investorvote.com/DHRM.
- To attend the meeting in person, please come to the Company's office at Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District, Beijing, 100856, PRC.
- Conference call information:
Toll Free: +1-888-213-3710
International Toll: +1-913-312-0677
Dial In (From China): +86-400-120-2696
Conference ID: 9877768
The Board of Directors of the Company has fixed the close of business on June 12, 2014 as the record date (the "Record Date") for determining the shareholders entitled to receive notice of the annual general meeting or any adjournment or postponement thereof.
Holders of record and beneficial owners of the Company's common shares at the close of business on the Record Date are entitled to attend the annual general meeting and any adjournment or postponement thereof in person.
It is important that your shares be represented and voted at our Annual General Meeting. If you have any problems voting or need assistance, please feel free to contact the Company by telephone at +86 10-5166-0080 or by email at firstname.lastname@example.org.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and ten software copyrights. More information can be found at http://www.dehaier.com.cn
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.